That epigenetic changes may be causally contributing to cancers is supported by the developmental loss of IGF-II imprinting being associated with the most common solid cancer in childhood, Wilms’ tumours [125] and also with the constitutional loss of IGF-II imprinting in Beckwith–Wiedemann syndrome being associated with an increased risk of cancer [126]. This evidence concerns the gene IGF2 and cancer.